Borrelia burgdorferi Osp A Antibodies

Santa Cruz Biotechnology delivers a wide array of Borrelia burgdorferi Osp A monoclonal antibodies for research in understanding Lyme disease and its causative agent. Borrelia burgdorferi Osp A Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Osp A, or outer surface protein A, plays a crucial role in the life cycle of Borrelia burgdorferi, facilitating the bacterium's survival and transmission between hosts. Understanding the function of Osp A is essential for developing effective diagnostics and therapeutics for Lyme disease, as it is a key antigen recognized by the immune system. The study of Borrelia burgdorferi Osp A is vital for advancing our knowledge of host-pathogen interactions and improving public health responses to tick-borne diseases. Researchers can utilize Borrelia burgdorferi Osp A monoclonal antibodies to investigate transmission mechanisms and potential therapeutic targets. Exploring the molecular aspects of Borrelia burgdorferi Osp A can lead to breakthroughs in prevention strategies and treatment options. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to combat Lyme disease and enhance public health outcomes.